Concepedia

Andrei Gafita

AG

Statistics

Publications

50

Citations

3K

H-Index

28

Active since

2018

Affiliations

TUM Klinikum(Current)

University of California, Los Angeles

Technical University of Munich

University of Duisburg-Essen

Molecular Theranostics (United States)

Andrei Gafita is an author at TUM Klinikum specializing in medicine, nuclear medicine, and prostate cancer.

ORCID

Publications per year

2018–2025

50

Publications

50

Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer

Matthias Heck, Robert Tauber, Sebastian Schwaiger et al. · European Urology · 2018 · 308 citations

, , +17

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

Benedikt Feuerecker, Robert Tauber, Karina Knorr et al. · European Urology · 2020 · 267 citations

, , +14

Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study

Andrei Gafita, Jérémie Calais, Tristan Grogan et al. · The Lancet Oncology · 2021 · 246 citations · Full text

, , +17

Matched-Pair Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and <sup>18</sup>F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy

Isabel Rauscher, Michael König, Andrei Gafita et al. · Journal of Nuclear Medicine · 2019 · 238 citations · Full text

, , +17

Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study

Andrei Gafita, Isabel Rauscher, Manuel Weber et al. · Journal of Nuclear Medicine · 2022 · 136 citations · Full text

, , +17

1–5 of 50